titoli, abstracts, parole chiave >>>
Galactosyl derivative of Nω-nitro-L-arginine: study of antiproliferative activity on human thyroid follicular carcinoma cells

Melisi, Daniela and Rosso, Francesco and Curcio, Annalisa and Tortora, Carla and Nieddu, Maria and Marino, Gerardo and Lettieri, Maria and Grimaldi, Anna and Luongo, Elvira and Romano, Simona and Romano, Maria Fiammetta and Boatto, Gianpiero and Abignente, Enrico and Barbarisi, Alfonso and Rimoli, Maria Grazia (2009) Galactosyl derivative of Nω-nitro-L-arginine: study of antiproliferative activity on human thyroid follicular carcinoma cells. Journal of Cellular Physiology, Vol. 221 (2), p. 240-247. eISSN 1097-4652. Article.

Full text not available from this repository.

DOI: 10.1002/jcp.21876

Abstract

The methyl ester prodrug of Nω-nitro-L-arginine (L-NAME) has been reported to exert anticancer effects against several human tumors, including thyroid carcinoma, by inhibiting nitric oxide synthase (NOS). However, chronic administration of L-NAME has often led to adverse events causing cardiovascular alterations due to its potential toxic effect. Here we report for the first time the synthesis of the galactosyl ester prodrug of Nω-nitro-L-arginine, NAGAL, a prodrug capable of inhibiting NOS more efficiently and with fewer adverse events than its parent drug. For this purpose RO82-W-1, a thyroid cell line derived from human follicular carcinoma, was used. MTT test results showed that NAGAL affected cell viability to a significantly greater extent than did L-NAME. Moreover, fluorescence activated cell sorter (FACS) analyses revealed that NAGAL, compared to L-NAME, was able to reduce nitric oxide (NO) production as well as increase the percentage of apoptotic thyreocytes. Western blot further confirmed the reduction in NOS-II expression by NAGAL. Finally, by using the LC-MS technique, we found that NAGAL elicited a higher increase in Nω-nitro-L-arginine (NA) concentration than did L-NAME. Thus, this study suggests that NAGAL could be considered a potential therapeutic tool for those pathologies involving an overproduction of NO, including thyroid carcinoma.

Item Type:Article
ID Code:3491
Status:Published
Refereed:Yes
Uncontrolled Keywords:Prodrugs, galactosyl derivatives
Subjects:Area 03 - Scienze chimiche > CHIM/08 Chimica farmaceutica
Divisions:001 Università di Sassari > 01 Dipartimenti > Farmaco, chimico, tossicologico
Publisher:Wiley-Liss
eISSN:1097-4652
Deposited On:26 Jan 2010 10:55

I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore

Repository Staff Only: item control page